Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Limited has informed BSE that its insider trading window will be closed from 1st July 2025 until 48 hours after the conclusion of the upcoming Board Meeting, which will consider the Un-Audited Financial Results for the quarter ended 30th June 2025. This is a standard compliance action taken under SEBI's Insider Trading Regulations, 2015, restricting designated persons (directors, officers, employees, and their immediate relatives) from trading in the company's shares during this blackout period. The exact date of the Board Meeting will be communicated to the exchange separately. The intimation was signed by Director Prakash Shah (DIN: 01136800) on 26th June 2025.
This is a routine regulatory filing and not a material event for shareholders. It does, however, signal that the Q1 FY26 results announcement is likely coming within the next few weeks, which investors should watch for. No immediate impact on share price is expected from the window closure itself.